Rigel Pharmaceuticals Inc — Cash Flow (NASDAQ:RIGL) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -52.19 M5.88 M-73.76 M-5.74 M31.47 M75.66 M 75.66 M Cash from investing activities 47.47 M-80.04 M72.78 M-4.3 M4.13 M-92.36 M -92.36 M Cash from financing activities 12.57 M62.67 M6.55 M18.37 M-11.64 M601 K 601 K Free cash flow -53.45 M5.25 M-74.21 M-20.74 M31.11 M75.66 M 75.66 M

뉴스

Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Micron and Coinbase among market cap stock movers on Wednesday

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

Rigel, 연간 60% 성장, 유망한 MDS 데이터 발표

Rigel Q4 2025 slides: 60% annual growth, promising MDS data

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan

Implied Volatility Surging for Rigel Pharmaceuticals Stock Options

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates